Saturday, June 15, 2024

LATYPOVA: There are no requirements for inspection of biologics manufacturing facilities by the FDA. This requirement was removed by Scott Gottlieb [per] admin rule change in 2019. Whatever is being produced is entirely open to adulteration, and this applies to all biologics, not just COVID

Elaborated here at Sasha Latypova's Substack

No comments:

Post a Comment